You are here

Article Text

Article menu
Download PDFPDF
Letter
Risk of gastric carcinoma in patients with atrophic gastritis and intestinal metaplasia
  1. J Y Kang,
  2. C Finlayson,
  3. J D Maxwell,
  4. P Neild
  1. Departments of Gastroenterology and Histopathology, St George’s Hospital, London, UK.
  1. Correspondence to:
    J Y Kang, Department of Gastroenterology, St George’s Hospital, Blackshaw Road, London SW17 0QT, UK;
    jykang{at}sghms.ac.uk

https://doi.org/10.1136/gut.51.6.899

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the study of Whiting et al (

    ) in which they reported an 11% risk of development of malignancy among patients with atrophic gastritis and intestinal metaplasia over a 10 year period. We agree with their conclusion that their findings should be further evaluated in larger studies, as confirmation of a high risk of malignancy would have important implications for clinical practice. We would however like to raise two issues.

    Firstly, in Whiting’s study, biopsies were taken only when there was macroscopic abnormality. These patients may …

    View Full Text